Table 1.

Baseline characteristics among PVD patients undergoing TAVR versus SAVR

	Unmatched		Matched
	SAVR-PVD (n = 18,451)	TAVR-PVD (n = 42,531)	SAVR-PVD (n = 12,020)	TAVR-PVD (n = 12,141)	Standardized mean difference
Age, years (mean + SD)	68.6 + 10.3	79.3 + 8.0	72.5 + 7.9	72.5 + 7.9	0.00
Female	27.2%	34.9%	29.0%	31.6%	0.05
Chronic kidney disease stage [3–5]	24.0%	43.9%	30.5%	34.0%	0.08
Chronic heart failure	47.3%	81.9%	62.9%	64.0%	0.02
Chronic pulmonary disease	26.9%	33.6%	30.9%	33.8%	0.07
Hypertension	87.9%	93.2%	90.9%	91.5%	0.02
Diabetes mellitus	33.3%	39.3%	37.0%	42.2%	0.10
Cancer	4.3%	5.9%	5.0%	5.1%	0.02
Obstructive sleep apnea	16.6%	15.0%	16.6%	17.1%	0.03
Smoking	52.1%	49.5%	52.3%	54.4%	0.04
Obesity	25.9%	17.5%	24.1%	24.8%	0.02
Liver disease	4.3%	3.0%	4.2%	4.2%	0.00
Insurance					– 0.02
Medicare	68.2%	90.7%	80.7%	83.4%
Medicaid	5.5%	1.1%	3.3%	2.8%
Private insurance	22.4%	5.5%	13.1%	10.0%
Self-pay	1.3%	0.3%	0.9%	0.6%
Number of vascular bed diseases	2-vessel (86.5%)/3-vessel (13.5%)	2-vessel (91.0%)/ 3-vessel (9.0%)	2-vessel (87.3%)/3-vessel (12.7%)	2-vessel (89.5%)/ 3-vessel (10.5%)	0.07

SD standard deviation, BMI body mass index, SD standard deviation